Fertility-sparing surgery for ovarian low malignant potential tumors

被引:37
|
作者
Rao, GG
Skinner, EN
Gehrig, PA
Duska, LR
Miller, DS
Schorge, JO
机构
[1] Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Dallas, TX 75390 USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA
关键词
fertility-sparing surgery; ovarian borderline tumor;
D O I
10.1016/j.ygyno.2005.04.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Ovarian low malignant potential (LMP) tumors have an excellent prognosis when treated by surgical resection. Conservative management usually involves leaving behind the uterus and contralateral adnexa to allow future childbearing. The purpose of this study was to determine the outcome of women treated with fertility-sparing surgery. Methods. All patients diagnosed with ovarian LMP tumors between 1984 and 2003 were identified at three institutions. Data were retrospectively extracted from clinical records. Results. Thirty-eight (15%) of 249 women with LMP tumors underwent fertility-sparing surgery. Twenty-three were nulliparous and four primiparous. Thirty-three (87%) underwent unilateral salpingo-ophorectomy and five (13%) cystectomy. Fourteen patients also had contralateral cystectomy or biopsy. Thirty-four (89%) were stage I, one (3%) stage II and three (8%) stage III. Most tumors had serous (55%) or mucinous (42%) histology. No patients received adjuvant therapy. Six (16%) of 38 recurred after a median follow-up of 26 months: five in the remaining ovary were salvaged with surgical resection alone, and none died from recurrent LMP tumor. Five women delivered six term infants during post-treatment surveillance. Conclusion. Fertility-sparing surgery for ovarian LMP tumors is an option for motivated patients. Preservation of the contralateral adnexa increases the risk of recurrence, but surgical resection is usually curative. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 50 条
  • [1] Fertility preservation for women with borderline ovarian tumors: fertility-sparing surgery
    Kim, S. Samuel
    [J]. FERTILITY AND STERILITY, 2021, 115 (01) : 83 - 84
  • [2] Borderline ovarian tumors, fertility-sparing surgery and pregnancy outcome
    Frega, A.
    Coluccia, A. C.
    Di Martino, G.
    Catalano, A.
    Milazzo, G. N.
    Assorgi, C.
    Manzara, F.
    Romeo, G. D.
    Gentile, M.
    Marziani, R.
    Moscarini, M.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 281 - 284
  • [3] Pregnancy after fertility-sparing surgery for borderline ovarian tumors
    Lian, Chengying
    Chen, Xiujuan
    Ni, Yihua
    Huang, Xiaochen
    Lin, Yuan
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 134 (03) : 282 - 285
  • [4] Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors
    Turkmen, Osman
    Karalok, Alper
    Basaran, Derman
    Kimyon, Gunsu Comert
    Tasci, Tolga
    Ureyen, Isin
    Tulunay, Gokhan
    Turan, Taner
    [J]. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2017, 6 (02) : 270 - 276
  • [5] Fertility-Sparing Surgery for Ovarian Cancer
    Canlorbe, Geoffroy
    Chabbert-Buffet, Nathalie
    Uzan, Catherine
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [6] Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 75 - 82
  • [7] FERTILITY-SPARING SURGERY IN PATIENTS WITH BORDERLINE OVARIAN TUMORS AND REPRODUCTIVE OUTCOMES
    Helmut, P.
    Harter, P.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Heikaus, S.
    Traut, A.
    du Bois, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A47 - A48
  • [8] FERTILITY-SPARING SURGERY (FSS) IN PATIENTS WITH BORDERLINE OVARIAN TUMORS (BOT)
    Vdovichenko, N.
    Harter, P.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Kurzeder, K.
    Heikaus, S.
    Weikel, W.
    Fisseler-Eckhoff, A.
    Traut, A.
    du Bois, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1568 - 1568
  • [9] Fertility-sparing surgery (FSS) in patients with borderline ovarian tumors (BOT)
    Vdovichenko, N.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Kurzeder, C.
    Heikaus, S.
    Weikel, W.
    Fisseler-Eckhoff, A.
    Alexander, T.
    du Bois, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 92 - 92
  • [10] FERTILITY OUTCOME AFTER FERTILITY-SPARING SURGERY OF MALIGNANT OVARIAN GERM CELL TUMOUR
    Bouyou, J.
    Bentivegna, E.
    Maulard, A.
    Pautier, P.
    Genestie, C.
    Gouy, S.
    Morice, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A113 - A113